BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37852159)

  • 61. The prevalence of cardiovascular disease risk factors and the Framingham Risk Score in patients undergoing percutaneous intervention over the last 17 years by gender: time-trend analysis from the Mayo Clinic PCI Registry.
    Lee MS; Flammer AJ; Kim HS; Hong JY; Li J; Lennon RJ; Lerman A
    J Prev Med Public Health; 2014 Jul; 47(4):216-29. PubMed ID: 25139168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treating high blood pressure in diabetes: the evidence.
    Adler AI
    Semin Vasc Med; 2002 May; 2(2):127-37. PubMed ID: 16222604
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
    Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    Lancet Diabetes Endocrinol; 2022 Sep; 10(9):645-654. PubMed ID: 35878651
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Factors associated with poor blood pressure control in hypertensive black Africans: cross-sectional study of 456 hypertensive patients from Burkina Faso].
    Yaméogo NV; Kagambèga LJ; Millogo RC; Kologo KJ; Yaméogo AA; Mandi GD; Ilboudo E; Toguyeni BJ; Samadoulougou AK; Zabsonré P
    Ann Cardiol Angeiol (Paris); 2013 Feb; 62(1):38-42. PubMed ID: 22677180
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blood pressure control and impact on cardiovascular events in patients with type 2 diabetes mellitus: A critical analysis of the literature.
    Vargas-Uricoechea H; Cáceres-Acosta MF
    Clin Investig Arterioscler; 2019; 31(1):31-47. PubMed ID: 30274771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).
    Piniés JA; González-Carril F; Arteagoitia JM; Irigoien I; Altzibar JM; Rodriguez-Murua JL; Echevarriarteun L;
    Diabetologia; 2014 Nov; 57(11):2324-33. PubMed ID: 25212259
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
    Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK
    J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
    Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
    Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey.
    Kabakcı G; Aydın M; Demir I; Kırma C; Özerkan F
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):313-20. PubMed ID: 21200100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.
    J Hypertens; 1993 Mar; 11(3):309-17. PubMed ID: 8387089
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Choice of antihypertensive drug in the diabetic patient.
    Ong HT; Cheah JS
    MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.
    Grimes RT; Ensor J; Bennett K; Henman MC
    Prim Care Diabetes; 2016 Aug; 10(4):237-43. PubMed ID: 26654852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.
    Giorda CB; Avogaro A; Maggini M; Lombardo F; Mannucci E; Turco S; Alegiani SS; Raschetti R; Velussi M; Ferrannini E;
    Diabetes Care; 2008 Nov; 31(11):2154-9. PubMed ID: 18782902
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Implications of the United Kingdom prospective diabetes study.
    Baldeweg SE; Yudkin JS
    Prim Care; 1999 Dec; 26(4):809-27. PubMed ID: 10523461
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Isolated microalbuminuria indicates a poor medical prognosis.
    Scheven L; Van der Velde M; Lambers Heerspink HJ; De Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2013 Jul; 28(7):1794-801. PubMed ID: 23493327
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
    McConaghy JR
    J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
    [No Abstract]   [Full Text] [Related]  

  • 79. Predicted risk of coronary heart disease among persons with type 2 diabetes.
    Kirk JK; Bertoni AG; Case D; Bell RA; Goff DC; Narayan KM
    Coron Artery Dis; 2007 Dec; 18(8):595-600. PubMed ID: 18004108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cardiovascular Risk and Atherosclerosis Progression in Hypertensive Persons Treated to Blood Pressure Targets.
    Gronewold J; Kropp R; Lehmann N; Stang A; Mahabadi AA; Kälsch H; Weimar C; Dichgans M; Budde T; Moebus S; Jöckel KH; Erbel R; Hermann DM
    Hypertension; 2019 Dec; 74(6):1436-1447. PubMed ID: 31679426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.